Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
Main Authors: | Jingjing Ji, Jinxia Zhang, Ziyun Shao, Qifeng Xie, Li Zhong, Zhifeng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-03287-6 |
Similar Items
-
Viral Clearance Course of COVID-19 Outbreaks
by: Samrah SM, et al.
Published: (2021-03-01) -
Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b
by: Akira Sato, et al.
Published: (2016-08-01) -
Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers
by: Tongyang Xiao, et al.
Published: (2021-03-01) -
In-line monitoring of surfactant clearance in viral vaccine downstream processing
by: Jessie Payne, et al.
Published: (2021-01-01) -
To study duration of viral clearance in COVID 19 patients: A Prospective study from Bangalore, India
by: Swetha Rajoli, et al.
Published: (2021-08-01)